ADENOCARCINOMA OF SALIVARY GLAND

This adverse event was reported 39 times

These drugs are most commonly taken by patients reporting ADENOCARCINOMA OF SALIVARY GLAND:

# Drug Count
0 CARBOPLATIN 9
1 METHOTREXATE SODIUM 9
2 PEMIGATINIB 9
3 CAPECITABINE 8
4 METHOTREXATE 8
5 ADALIMUMAB 6
6 ADALIMUMAB-AATY 6
7 ADALIMUMAB-ADAZ 6
8 ADALIMUMAB-FKJP 6
9 APREMILAST 6
See all common drugs associated with ADENOCARCINOMA OF SALIVARY GLAND

ADENOCARCINOMA OF SALIVARY GLAND is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEMIGATINIB 9 0.0106
1 LAROTRECTINIB 2 0.0022
2 RITUXIMAB-ABBS 2 0.0004
3 VINORELBINE 1 0.0001
4 ADALIMUMAB-FKJP 6 0.0001
5 ADALIMUMAB-AATY 6 0.0001
6 ADALIMUMAB-ADAZ 6 0.0001
7 CAPECITABINE 8 0.0001
8 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 1 0.0001
9 CRIZOTINIB 1 0.0001
See all drugs enriched for association with ADENOCARCINOMA OF SALIVARY GLAND